Avita Medical | 1811094D - Debt


Avita Medical reported AUD44.59M in Debt for its fiscal semester ending in June of 2025.





Debt Change Date
Accuray USD 170.24M 4.52M Sep/2024
Celltrion KRW 171.09B 2.05T Jun/2025
Clinuvel Pharmaceuticals AUD 879.78K 189.09K Jun/2024
Cochlear AUD 235.7M 10.9M Jun/2025
CSL USD 11.96B 219M Dec/2024
Cspc Pharmaceutical CNY 495M 12.33M Jun/2025
Deva Holding AS TRY 5.3B 871.93M Sep/2023
Dianthus Therapeutics USD 1.28M 45K Sep/2025
Divis Laboratories Ltd INR 40M 40M Mar/2025
Kangmei Pharma CNY 131.64M 90.18M Jun/2025
Knight Therapeutics CAD 106.24M 1.5M Sep/2025
Laboratorios Farma EUR 129.3M 14.89M Jun/2025
Malin Corporation EUR 100K 0 Dec/2023
Mayne Pharma AUD 38.82M 2.24M Jun/2024
Medical Developments International AUD 1.99M 152K Jun/2025
Nanosonics AUD 7.69M 1.49M Jun/2025
Neuren Pharmaceuticals AUD 0 0 Dec/2024
Ovoca Bio EUR 0 0 Jun/2021
Pacific Edge NZD 2.9M 425K Mar/2025
Paradigm Biopharmaceuticals AUD 181.4K 38.99K Dec/2024
Pharma Mar EUR 51.4M 405K Jun/2025
Polynovo AUD 15.38M 49K Jun/2024
PYC Therapeutics AUD 1.02M 185.07K Jun/2025
Qiagen NV USD 2.13B 683.16M Sep/2025
Ramsay Health Care AUD 12.12B 864.4M Jun/2025
ResMed USD 846.35M 5.46M Sep/2025
Sartorius EUR 4.66B 25.7M Jun/2025
Sino Biopharmaceutical CNY 9.71B 33.98M Dec/2024
Telix Pharmaceuticals AUD 418.25M 163.2M Jun/2025
Tilray USD 640.95M 35.17M Jun/2022
Zz Pientze Pharmaceu CNY 1.07B 52.69M Jun/2025